USPTO 2015–2025 USPTO PatentsView US Corporation

Clear Labs, Inc

USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Clear ranks #26,015 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 8 technology areas.

#26,015
of 49,997 US assignees by volume
Top 35%
by Innovation Score (40.6/100)
22.4
avg claims per patent
+100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26015 · US Corporation #26,015 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #26,015/49,997
  • PHOTO-FINISH Clarcor Air…
  • CPC-NARROW C12Q · 8 areas
  • INNOV-PAR 40.6/100
  • CLAIMS-DENSE 22.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Clarcor Air Filtration Products, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clear’s 40.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Clear

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Clear's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Clear?

Each dot is one of Clear’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clear’s own 22.4 claims/patent is ABOVE the 18.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Clear vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 9.99.91010.1 0100200300 Granted patents (volume) Avg claims / patent ClarVista Medical, Inc. - 10, 20.4Clarvista MedicalClarcor Air Filtration Products, Inc. - 10, 22.7Clarcor Air Filtr…Claussen Technology, LLC - 10, 11Claussen Technolo…Clean Hands Safe Hands LLC - 10, 18.9Clean Hands Safe…ClearingBid, Inc. - 10, 278.5ClearingbidCleveland BioLabs, Inc. - 10, 16.7Cleveland BiolabsCloud Dx, Inc. - 10, 17.4Cloud DxCloudPassage, Inc. - 10, 31.3CloudpassageClear Labs, Inc - 10, 22.4Clear Labs
Clear vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clear's grants concentrate

Clear Labs, Inc is a focused PatentsView assignee: 8 CPC subclasses with 90% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2019. By volume, Clear sits between ClarVista Medical, Inc. and CloudPassage, Inc..

Clear's three-year grant acceleration

Clear Labs, Inc shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Clear's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Clear holds 10 patents at rank #26,046, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Clear

By rank, the assignees closest to #26,046 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Clear's primary technology class.

Clear's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201820192020202220232025 1
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Clear Labs, Inc patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 20.0%
2019 1 10.0%
2020 2 20.0%
2022 2 20.0%
2023 2 20.0%
2025partial year 1 10.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Clear Labs, Inc's patent record in context - here's where to go next.

  • Clear Labs, Inc's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 90% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #26,015 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Clear Labs, Inc against ClarVista Medical, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.